3 Solar Energy Company, Tyres Maker and Generic Injectables Pharma Company Stocks With a Strong Future Roadmap: Waaree Energies, MRF and Caplin Point Laboratories

Solar, tyre and pharma exporter stocks offer a focused view of a sector where demand keeps widening. Waaree Energies, MRF and Caplin Point Laboratories cover a solar energy company, a tyres maker and a generic injectables pharma company.

This list covers three solar, tyre and pharma exporter stocks with complete current figures: Waaree Energies, MRF and Caplin Point Laboratories. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Solar, Tyre and Pharma Exporter Stocks?

Solar, tyre and pharma exporter stocks are listed companies that make solar cells and modules for utilities and rooftops, make tyres for cars, trucks, two wheelers and farm vehicles, and make generic injectables and tablets for Latin America and other markets. Their earnings depend on solar installations, tyre sales and export orders.

Solar, Tyre and Pharma Exporter Stocks at a Glance

On valuation, Waaree Energies and Caplin Point Laboratories trade at a P/E below the industry P/E, while MRF trades above it, which reflects the growth the market already expects. Readers comparing solar, tyre and pharma exporter stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Solar, Tyre and Pharma Exporter Stocks Have a Strong Roadmap in India?

Solar, tyre and pharma exporter stocks have a strong roadmap in India because rapid solar capacity additions, a rising vehicle base and growing demand for affordable medicines in emerging markets keep widening the market for these companies.

• Solar. Utilities and homes add clean energy fast.
• Tyres. More vehicles on the road need more tyres.
• Generic pharma. Emerging markets need affordable medicines.

Why Waaree Energies Features Among These Solar, Tyre and Pharma Exporter Stocks

Among the solar, tyre and pharma exporter stocks on this list, Waaree Energies is one of India's largest manufacturers of solar photovoltaic modules, with factories in Gujarat, and it also provides solar project engineering and has expanded into cells and related products.

Revenue rose from Rs 2,951 crore in FY22 to Rs 27,245 crore in FY26, a compound annual growth rate of 74.3%. Net profit grew from Rs 1,274 crore in FY24 to Rs 3,884 crore in FY26, which works out to a compound annual growth rate of 74.6%.

The company has a return on equity of 25.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 72,290 crore. The stock trades at a P/E of 18.1, below the industry P/E of 43.9.

Roadmap: The company is adding module, cell and wafer capacity to build a deeper in-house supply chain, in line with domestic manufacturing incentives and rapid growth in solar installations. A strong order book from domestic and overseas customers supports volumes.

What to watch: Track the commissioning of new cell and module capacity and the order book for the coming quarters.

Why MRF Features Among These Solar, Tyre and Pharma Exporter Stocks

Among the panel maker, rubber wheel and medicine shares on this list, MRF is one of India's largest tyre makers, producing tyres for two-wheelers, cars, trucks, buses and farm vehicles, along with tubes, treads and conveyor belts, and it has one of the strongest brand names in the industry.

The company has a return on equity of 11.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 49,998 crore. The stock trades at a P/E of 20.7, above the industry P/E of 19.2.

Revenue rose from Rs 19,634 crore in FY22 to Rs 31,654 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 669 crore in FY22 to Rs 2,426 crore in FY26, which works out to a compound annual growth rate of 38.0%. In the June 2026 quarter, revenue grew 10.3% year on year to Rs 8,611 crore.

Roadmap: The company has steadily added radial and premium capacity and benefits from a very large replacement market. A strong balance sheet lets it invest through demand cycles.

What to watch: Track replacement demand, rubber and crude-linked input costs and new capacity additions.

Why Caplin Point Laboratories Features Among These Solar, Tyre and Pharma Exporter Stocks

Among the three companies on this list, Caplin Point Laboratories, based in Chennai, sells branded generic medicines in Latin America and other emerging markets and has built a regulated-market business through its sterile injectables arm.

Revenue rose from Rs 1,308 crore in FY22 to Rs 2,303 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 308 crore in FY22 to Rs 650 crore in FY26, which works out to a compound annual growth rate of 20.5%.

In the June 2026 quarter, revenue grew 20.7% year on year to Rs 644 crore, while net profit rose 18.8% to Rs 179 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 17,194 crore. The stock trades at a P/E of 25.4, below the industry P/E of 36.0.

Roadmap: The company combines a high-return emerging-market distribution model with a growing US injectables portfolio. New approvals from its sterile facilities and expansion of its local distribution reach support the next leg of growth.

What to watch: Follow new US product approvals and currency trends in Latin American markets.

Waaree Energies vs MRF vs Caplin Point Laboratories on Key Financials

The table below sets the three solar, tyre and pharma exporter stocks side by side on revenue, profit and margin, using reported figures.

Waaree Energies posts the highest return on equity in this group at 25.7%. MRF has the largest FY26 revenue at Rs 31,654 crore, and Waaree Energies shows the fastest revenue growth with a 74.3% compound annual rate. A useful habit with solar, tyre and pharma exporter stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Solar, Tyre and Pharma Exporter Stocks

Every theme carries risks that deserve a check before any decision. For these solar, tyre and pharma exporter stocks, the main points are: Long-term panel maker, rubber wheel and medicine shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Module prices. Solar equipment prices and policy support can change returns.
• Rubber and carbon black costs. Raw material prices can move margins.
• Currency moves. Export earnings move with the rupee.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter solar, tyre and pharma exporter stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Solar, Tyre and Pharma Exporter Stocks

Solar, tyre and pharma exporter stocks reward patient research into demand, execution and financial strength. Waaree Energies, MRF and Caplin Point Laboratories each have a clear plan to grow. Based on the 11 November 2026 close, Waaree Energies trades at Rs 2,500, MRF at Rs 127,125 and Caplin Point Laboratories at Rs 2,520.3. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these solar, tyre and pharma exporter stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track solar, tyre and pharma exporter stocks, set price alerts and get research-backed stock ideas.

What are solar, tyre and pharma exporter stocks?

Ans. Solar, tyre and pharma exporter stocks are listed companies that make solar cells and modules for utilities and rooftops, make tyres for cars, trucks, two wheelers and farm vehicles, and make generic injectables and tablets for Latin America and other markets. Their earnings depend on solar installations, tyre sales and export orders. This list looks at three of them, Waaree Energies, MRF and Caplin Point Laboratories, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.

Which solar, tyre and pharma exporter stocks are covered in this list?

Ans. This list covers Waaree Energies, MRF and Caplin Point Laboratories. Based on the 11 November 2026 close, Waaree Energies traded at Rs 2,500, MRF at Rs 127,125 and Caplin Point Laboratories at Rs 2,520.3. Their return on equity ranges from 11.6% to 25.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.7% to 74.3%.

Why do solar, tyre and pharma exporter stocks have a strong future roadmap in India?

Ans. Solar, tyre and pharma exporter stocks have a strong roadmap in India because rapid solar capacity additions, a rising vehicle base and growing demand for affordable medicines in emerging markets keep widening the market for these companies. The main drivers are as follows. Solar. Utilities and homes add clean energy fast. Tyres. More vehicles on the road need more tyres. Generic pharma. Emerging markets need affordable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Waaree Energies performed financially?

Ans. Revenue rose from Rs 2,951 crore in FY22 to Rs 27,245 crore in FY26, a compound annual growth rate of 74.3%. Net profit grew from Rs 1,274 crore in FY24 to Rs 3,884 crore in FY26, which works out to a compound annual growth rate of 74.6%. The company has a return on equity of 25.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 72,290 crore. The stock trades at a P/E of 18.1, below the industry P/E of 43.9. Looking ahead, the company is adding module, cell and wafer capacity to build a deeper in-house supply chain, in line with domestic manufacturing incentives and rapid growth in solar installations. A strong order book from domestic and overseas customers supports volumes.

How has MRF performed financially?

Ans. Revenue rose from Rs 19,634 crore in FY22 to Rs 31,654 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 669 crore in FY22 to Rs 2,426 crore in FY26, which works out to a compound annual growth rate of 38.0%. In the June 2026 quarter, revenue grew 10.3% year on year to Rs 8,611 crore. The company has a return on equity of 11.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 49,998 crore. The stock trades at a P/E of 20.7, above the industry P/E of 19.2. Looking ahead, the company has steadily added radial and premium capacity and benefits from a very large replacement market. A strong balance sheet lets it invest through demand cycles.

How has Caplin Point Laboratories performed financially?

Ans. Revenue rose from Rs 1,308 crore in FY22 to Rs 2,303 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 308 crore in FY22 to Rs 650 crore in FY26, which works out to a compound annual growth rate of 20.5%. In the June 2026 quarter, revenue grew 20.7% year on year to Rs 644 crore, while net profit rose 18.8% to Rs 179 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 17,194 crore. The stock trades at a P/E of 25.4, below the industry P/E of 36.0. Looking ahead, the company combines a high-return emerging-market distribution model with a growing US injectables portfolio. New approvals from its sterile facilities and expansion of its local distribution reach support the next leg of growth.

What risks should investors check before buying solar, tyre and pharma exporter stocks?

Ans. Investors should check a few risks before buying solar, tyre and pharma exporter stocks. Module prices. Solar equipment prices and policy support can change returns. Rubber and carbon black costs. Raw material prices can move margins. Currency moves. Export earnings move with the rupee. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of solar, tyre and pharma exporter stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.